Immunological aspects of allogeneic pancreatic islet transplantation: a comparison between mouse and human

Pancreatic islet allotransplantation is a treatment for patients with severe forms of type 1 diabetes. As long‐term graft function and survival are not yet optimal, additional studies are warranted in order to continue improving transplant outcomes. The mechanisms of islet graft loss and tolerance induction are often studied in murine diabetes models. Despite numerous islet transplantation studies successfully performed over recent years, translation from experimental mouse models to human clinical application remains elusive. This review aims at critically discussing the strengths and limitations of current mouse models of diabetes and experimental islet transplantation. In particular, we will analyze the causes leading to diabetes and compare the immunological mechanisms responsible for rejection between mouse and human. A better understanding of the experimental mouse models should facilitate translation to human clinical application.

[1]  T. P. Rohrig.  Tolerance , 2019, Postmortem Toxicology.

[2]  J. Odorico,et al.  Rebuilding a better home for transplanted islets , 2018, Organogenesis.

[3]  H. Thomas,et al.  Transplantation sites for human and murine islets , 2017, Diabetologia.

[4]  J. Markmann,et al.  Regulatory B Cell‐Dependent Islet Transplant Tolerance Is Also Natural Killer Cell Dependent , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5]  L. Beura,et al.  Implications of Resident Memory T Cells for Transplantation , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  C. Ricordi,et al.  Clinical pancreatic islet transplantation , 2017, Nature Reviews Endocrinology.

[7]  Q. Lu,et al.  Beyond Genetics: What Causes Type 1 Diabetes , 2017, Clinical Reviews in Allergy & Immunology.

[8]  K. Brayman,et al.  Single-donor islet transplantation in type 1 diabetes: patient selection and special considerations , 2017, Diabetes, metabolic syndrome and obesity : targets and therapy.

[9]  M. Alegre,et al.  Antigen Presentation in Transplantation. , 2016, Trends in immunology.

[10]  T. Berney,et al.  Immunogenicity of Anti-HLA Antibodies in Pancreas and Islet Transplantation , 2016, Cell transplantation.

[11]  T. Kay,et al.  Long-term effects of islet transplantation , 2016, Current opinion in organ transplantation.

[12]  D. Long,et al.  Effects of Adoptive Transfer of Tolerogenic Dendritic Cells on Allograft Survival in Organ Transplantation Models: An Overview of Systematic Reviews , 2016, Journal of immunology research.

[13]  P. de Vos,et al.  Selection of polymers for application in scaffolds applicable for human pancreatic islet transplantation , 2016, Biomedical materials.

[14]  W. Haining,et al.  Recapitulating adult human immune traits in laboratory mice by normalizing environment , 2016, Nature.

[15]  S. Grey,et al.  Antigen-Encoding Bone Marrow Terminates Islet-Directed Memory CD8+ T-Cell Responses to Alleviate Islet Transplant Rejection , 2016, Diabetes.

[16]  T. Donner,et al.  B cell-targeted immunotherapy for type 1 diabetes: What can make it work? , 2016, Discovery medicine.

[17]  R. Bottino,et al.  Current status of islet xenotransplantation. , 2015, International journal of surgery.

[18]  L. Piemonti,et al.  Monitoring Inflammation, Humoral and Cell-mediated Immunity in 
Pancreas and Islet Transplants , 2015, Current diabetes reviews.

[19]  A. Secchi,et al.  Clinical results of islet transplantation. , 2015, Pharmacological research.

[20]  D. Pardoll.  Distinct mechanisms of tumor resistance to NK killing: of mice and men. , 2015, Immunity.

[21]  J. Holgersson,et al.  Immunotoxicological effects of streptozotocin and alloxan: in vitro and in vivo studies. , 2015, Immunology letters.

[22]  J. Markmann,et al.  TGF‐β‐producing regulatory B cells induce regulatory T cells and promote transplantation tolerance , 2014, European journal of immunology.

[23]  F. Ginhoux,et al.  Monocytes and macrophages: developmental pathways and tissue homeostasis , 2014, Nature Reviews Immunology.

[24]  T. Berney,et al.  Survival of Free and Encapsulated Human and Rat Islet Xenografts Transplanted into the Mouse Bone Marrow , 2014, PloS one.

[25]  F. Ginhoux,et al.  Organization of the mouse and human DC network. , 2014, Current opinion in immunology.

[26]  W. Murphy,et al.  Utilization of mouse models to decipher natural killer cell biology and potential clinical applications. , 2013, Hematology. American Society of Hematology. Education Program.

[27]  Boris Gala-Lopez,et al.  Revascularization of Transplanted Pancreatic Islets and Role of the Transplantation Site , 2013, Clinical & developmental immunology.

[28]  L. Chatenoud,et al.  Intragraft mechanisms associated with the immunosuppressive versus the tolerogenic effect of CD3 antibodies in a mouse model of islet allografts. , 2013, Transplantation proceedings.

[29]  A. Drake.  Of mice and men: what rodent models don't tell us , 2013, Cellular and Molecular Immunology.

[30]  L. Piemonti,et al.  Murine animal models for preclinical islet transplantation , 2013, Islets.

[31]  R. Tisch,et al.  Autoreactive Effector/Memory CD4+ and CD8+ T Cells Infiltrating Grafted and Endogenous Islets in Diabetic NOD Mice Exhibit Similar T Cell Receptor Usage , 2012, PloS one.

[32]  D. Adams,et al.  Hepatic expression and cellular distribution of the glucose transporter family. , 2012, World journal of gastroenterology.

[33]  Y. Richard,et al.  Revisiting the B-cell compartment in mouse and humans: more than one B-cell subset exists in the marginal zone and beyond , 2012, BMC Immunology.

[34]  G. Morahan.  Insights into type 1 diabetes provided by genetic analyses , 2012, Current opinion in endocrinology, diabetes, and obesity.

[35]  A. King.  The use of animal models in diabetes research , 2012, British journal of pharmacology.

[36]  W. Wiersinga.  Current insights in sepsis: from pathogenesis to new treatment targets , 2011, Current opinion in critical care.

[37]  Y. Dor,et al.  Recognition and Killing of Human and Murine Pancreatic β Cells by the NK Receptor NKp46 , 2011, The Journal of Immunology.

[38]  V. Serre-Beinier,et al.  Immunosuppressive Effects of Streptozotocin-Induced Diabetes Result in Absolute Lymphopenia and a Relative Increase of T Regulatory Cells , 2011, Diabetes.

[39]  L. Piemonti,et al.  Alternative Transplantation Sites for Pancreatic Islet Grafts , 2011, Current Diabetes Reports.

[40]  N. Eberhardt,et al.  Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models , 2011, Laboratory animals.

[41]  Y. Mullen,et al.  Liver Natural Killer Cells Play a Role in the Destruction of Islets After Intraportal Transplantation , 2011, Transplantation.

[42]  S. Londrigan,et al.  Selective Depletion of Cross-Presenting Dendritic Cells Enhances Islet Allograft Survival , 2011, Cell transplantation.

[43]  A. Shapiro,et al.  Immune monitoring of pancreatic islet graft: towards a better understanding, detection and treatment of harmful events , 2011, Expert opinion on biological therapy.

[44]  Claudio Lottaz,et al.  Comparison of gene expression profiles between human and mouse monocyte subsets. , 2010, Blood.

[45]  Darrell M. Wilson,et al.  Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. , 2009, The New England journal of medicine.

[46]  A. Shapiro,et al.  Optimal implantation site for pancreatic islet transplantation , 2008, The British journal of surgery.

[47]  J. Ijzermans,et al.  The Choice of Anatomical Site for Islet Transplantation , 2008, Cell Transplantation.

[48]  R. Tisch,et al.  B Lymphocyte Depletion by CD20 Monoclonal Antibody Prevents Diabetes in Nonobese Diabetic Mice despite Isotype-Specific Differences in FcγR Effector Functions1 , 2008, The Journal of Immunology.

[49]  M. Magnani,et al.  Prolonged islet allograft survival in diabetic mice upon macrophage depletion by clodronate-loaded erythrocytes. , 2008, Transplantation.

[50]  L. Wen,et al.  Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. , 2007, The Journal of clinical investigation.

[51]  D. Mosser,et al.  Monocyte subpopulations and their differentiation patterns during infection , 2007, Journal of leukocyte biology.

[52]  P. Bingley,et al.  Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis. , 2007, Tissue antigens.

[53]  M. Schneemann,et al.  Macrophage biology and immunology: man is not a mouse , 2007, Journal of leukocyte biology.

[54]  C. Thivolet,et al.  Immunology of pancreatic islet transplantation. , 2006, Diabetes & metabolism.

[55]  Anna Moore,et al.  In Vivo Imaging of Immune Rejection in Transplanted Pancreatic Islets , 2006, Diabetes.

[56]  L. Kaer,et al.  NK cells promote islet allograft tolerance via a perforin-dependent mechanism , 2005, Nature Network Boston.

[57]  C. Hughes,et al.  Of Mice and Not Men: Differences between Mouse and Human Immunology , 2004, The Journal of Immunology.

[58]  C. Larsen,et al.  Heterologous immunity: an overlooked barrier to tolerance , 2003, Immunological reviews.

[59]  H. Auchincloss,et al.  Effects of streptozotocin on autoimmune diabetes in NOD mice , 2003, Clinical and experimental immunology.

[60]  T. Strom,et al.  Islet Allograft Rejection in Nonobese Diabetic Mice Involves the Common γ-Chain and CD28/CD154-Dependent and -Independent Mechanisms1 , 2003, The Journal of Immunology.

[61]  Diana C. Doeing,et al.  Gender dimorphism in differential peripheral blood leukocyte counts in mice using cardiac, tail, foot, and saphenous vein puncture methods , 2003, BMC clinical pathology.

[62]  P. Haley.  Species differences in the structure and function of the immune system. , 2003, Toxicology.

[63]  Colin N. Dewey,et al.  Initial sequencing and comparative analysis of the mouse genome. , 2002 .

[64]  Z. Kaleem,et al.  Rejection of porcine islet xenografts mediated by CD4+ T cells activated through the indirect antigen recognition pathway , 2002, Xenotransplantation.

[65]  G. Eisenbarth,et al.  Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice , 2002, Nature Medicine.

[66]  E. Bonifacio,et al.  International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice. , 2001, Diabetes.

[67]  D. Greiner,et al.  Islet cell transplantation tolerance. , 2001, Transplantation.

[68]  A. Fraire,et al.  Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung , 2001, Nature Immunology.

[69]  H. Mcdevitt.  Closing in on type 1 diabetes. , 2001, New England Journal of Medicine.

[70]  S. Martin,et al.  Development of type 1 diabetes despite severe hereditary B-cell deficiency. , 2001, The New England journal of medicine.

[71]  Christian Bogdan,et al.  Nitric oxide and the immune response , 2001, Nature Immunology.

[72]  H. Merkle,et al.  Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages? , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[73]  J F Elliott,et al.  Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. , 2001, Diabetes.

[74]  F. Sinigaglia,et al.  Substitution of aspartic acid at β57 with alanine alters MHC class II peptide binding activity but not protein stability: HLA-DQ (α1∗0201, β1∗0302) and (α1∗0201, β1∗0303) , 1999 .

[75]  M. Knip,et al.  Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group. , 1999, The Journal of clinical endocrinology and metabolism.

[76]  F. Krombach,et al.  Cell size of alveolar macrophages: an interspecies comparison. , 1997, Environmental health perspectives.

[77]  M. Atkinson,et al.  The pathogenesis of insulin-dependent diabetes mellitus. , 1994, The New England journal of medicine.

[78]  K. Welsh,et al.  T cell receptor beta chain polymorphisms are associated with insulin-dependent diabetes. , 1987, Clinical and experimental immunology.

[79]  H. Ohdan,et al.  Role of Natural Killer Cells in the Innate Immune System After Intraportal Islet Transplantation in Mice. , 2017, Transplantation proceedings.

[80]  L. Wen,et al.  The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes. , 2016, Journal of autoimmunity.

[81]  D. Serreze,et al.  Bridging Mice to Men: Using HLA Transgenic Mice to Enhance the Future Prediction and Prevention of Autoimmune Type 1 Diabetes in Humans. , 2016, Methods in molecular biology.

[82]  Claudio Lottaz,et al.  Comparison of gene expression profiles between human and mouse monocyte , 2016 .

[83]  H. Erlich,et al.  Genetics of type 1 diabetes. , 2012, Cold Spring Harbor perspectives in medicine.

[84]  R. Bottino,et al.  Metabolic aspects of pig-to-monkey (Macaca fascicularis) islet transplantation: implications for translation into clinical practice , 2007, Diabetologia.

[85]  Mouse Genome Sequencing Consortium.  Initial sequencing and comparative analysis of the mouse genome , 2002, Nature.

[86]  R. Gill,et al.  The basis of immunogenicity of endocrine allografts. , 2001, Critical reviews in immunology.

[87]  F. Sinigaglia,et al.  Substitution of aspartic acid at beta57 with alanine alters MHC class II peptide binding activity but not protein stability: HLA-DQ (alpha1*0201, beta1*0302) and (alpha1*0201, beta1*0303). , 1999, Human Immunology.